Does Zosyn (piperacillin/tazobactam) cover Trichomoniasis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

No, Zosyn (piperacillin/tazobactam) does not cover Trichomoniasis. Trichomoniasis is a sexually transmitted infection caused by the parasite Trichomonas vaginalis, which requires specific antiprotozoal medications for treatment.

Treatment Options

  • The first-line treatment for trichomoniasis is metronidazole, typically given as a single 2-gram oral dose, or alternatively as 500 mg twice daily for 7 days, as recommended by the Centers for Disease Control and Prevention 1.
  • Another effective option is tinidazole, given as a single 2-gram oral dose.

Rationale for Not Using Zosyn

  • Zosyn is an antibiotic combination that contains piperacillin (a penicillin-type antibiotic) and tazobactam (a beta-lactamase inhibitor), which is designed to treat bacterial infections, not parasitic infections like trichomoniasis.
  • Zosyn is primarily used for moderate to severe bacterial infections such as intra-abdominal infections, pneumonia, skin infections, and urinary tract infections.

Potential Consequences of Using the Wrong Antimicrobial Agent

  • Using the wrong antimicrobial agent, such as Zosyn, would fail to clear the trichomoniasis infection and could lead to persistent symptoms, transmission to partners, and potential complications.
  • The nitroimidazoles, including metronidazole, are the only class of drugs useful for the oral or parenteral therapy of trichomoniasis, with cure rates of approximately 90%--95% when using the recommended metronidazole regimens 1.

From the Research

Treatment of Trichomoniasis

  • Trichomoniasis is typically treated with metronidazole or tinidazole, with the latter being used for resistant cases 2, 3, 4, 5, 6
  • The standard treatment for trichomoniasis is a single dose of metronidazole, but a 7-day dose may be more effective in some cases 6
  • Alternative treatment options, such as disulfiram and nithiamide, have shown promise in treating resistant trichomoniasis 4
  • Combination therapy with tinidazole, a broad-spectrum antibiotic, and clotrimazole pessaries has also been effective in treating metronidazole-resistant trichomoniasis 5

Zosyn (Piperacillin/Tazobactam) Coverage

  • There is no evidence to suggest that Zosyn (piperacillin/tazobactam) is effective in treating trichomoniasis 2, 3, 4, 5, 6
  • The studies reviewed do not mention Zosyn as a treatment option for trichomoniasis, and instead focus on metronidazole, tinidazole, and other alternative treatments

Key Findings

  • Metronidazole and tinidazole are the primary treatments for trichomoniasis, with tinidazole being used for resistant cases 2, 3, 4, 5, 6
  • Alternative treatment options, such as disulfiram and nithiamide, may be effective in treating resistant trichomoniasis 4
  • Combination therapy with tinidazole, a broad-spectrum antibiotic, and clotrimazole pessaries may be effective in treating metronidazole-resistant trichomoniasis 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Management of Resistant Trichomoniasis.

Current infectious disease reports, 2019

Research

Nitroimidazoles in the treatment of trichomoniasis, giardiasis, and amebiasis.

International journal of clinical pharmacology, therapy, and toxicology, 1984

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.